MISONIX, Inc. (MSON): Price and Financial Metrics
GET POWR RATINGS... FREE!
MSON POWR Grades
- Sentiment is the dimension where MSON ranks best; there it ranks ahead of 95.74% of US stocks.
- MSON's strongest trending metric is Sentiment; it's been moving up over the last 200 days.
- MSON's current lowest rank is in the Momentum metric (where it is better than 15.17% of US stocks).
MSON Stock Summary
- Misonix Inc's stock had its IPO on March 25, 1993, making it an older stock than 78.19% of US equities in our set.
- Of note is the ratio of Misonix Inc's sales and general administrative expense to its total operating expenses; 76.7% of US stocks have a lower such ratio.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.4 for Misonix Inc; that's greater than it is for just 20.35% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Misonix Inc are SXI, PESI, MYE, ROAD, and EVI.
- Visit MSON's SEC page to see the company's official filings. To visit the company's web site, go to www.misonix.com.
MSON Stock Price Chart Interactive Chart >
MSON Price/Volume Stats
|Current price||$18.33||52-week high||$20.71|
|Prev. close||$18.81||52-week low||$9.06|
|Day high||$18.78||Avg. volume||55,061|
|50-day MA||$19.24||Dividend yield||N/A|
|200-day MA||$14.88||Market Cap||319.07M|
MISONIX, Inc. (MSON) Company Bio
Misonix, Inc. produces and distributes medical devices. The Company offers devices for spinal decompression, wound management, tumor removal, and general surgery. Misonix markets its products in the United States.
MSON Latest News Stream
|Loading, please wait...|
MSON Latest Social Stream
View Full MSON Social Stream
Latest MSON News From Around the Web
Below are the latest news stories about Misonix Inc that investors may wish to consider to help them evaluate MSON as an investment opportunity.
Misonix, Inc. (MSON) Q3 2021 Earnings Conference Call May 06, 2021, 16:30 ET Company Participants Norberto Aja - JCIR Stavros Vizirgianakis - CEO & Director Joseph Dwyer - CFO, Treasurer & Secretary Conference Call Participants Alexander Nowak - Craig-Hallum Ryan Zimmerman - BTIG Presentation Operator Good day, and welcome to...
Misonix Raises Guidance for neXus® Ultrasonic Surgical System to 200 Unit Placements by Fiscal 2021 Year-EndFARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021 third quarter ended March 31, 2021 as summarized below: Three Months Ended Nine Months Ended March 31, March 31, 2021 2020 2021 2020 Revenue$18,347,180 $17,902,512 $54,338,932 $48,770,419 Gross profit$12,944,426 $12,590,947 $38,560,879 $34,277,098 Gross profit percentage 70.6% 70.3% 71.0% 70.3%Pretax loss$(3,756,804) $(6,043,477) $(10,000,053) $(13,420,961)Income tax benefit$- $(455,000) $- $...
NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Misonix, Inc. (NASDAQ:MSON) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time.
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada license for the neXus® Ultrasonic Surgical System. This approval confirms that neXus meets the requirements of Health Canada, allowing Misonix to commercialize neXus, along with its various handpieces and disposable products, across Canada. Stavros Vizirgianakis, President and Chief Executive Officer of Misonix stated, “We are very pleased Health Canada has approved the use of neXus. This approval, along with our CE Mark certification, is further affirmation of our technology, and allows us to co...
MSON Price Returns